Loading…
Source: SEBI
As disclosed by the issuer.
| KPI | Value | Period | Pages |
|---|---|---|---|
| Basic EPS | ₹5.73 | 31.03.2026 | — |
| RoNW | 24.31% | 31.03.2026 | — |
| NAV per Equity Share | ₹26.59 | 31.03.2026 | — |
Iberia Pharmaceuticals India Limited is an Indian pharmaceutical and derma cosmetics company with a diverse product portfolio across aesthetic dermatology, hair care, cardio diabetic, and general therapeutics. The company markets products under proprietary brands such as Dermpix, Metacare, and KeyCi, as well as foreign brands like Sesderma and Mediderma.
The Indian pharmaceutical industry is projected to grow at a CAGR of 13-15%, reaching about USD 110-120 billion by FY30. The aesthetic dermatology market is also expanding, presenting growth opportunities for companies like Iberia Pharmaceuticals.